Tolazoline
CAS No. 59-98-3
Tolazoline ( Vasimid; Benzalolin; Divascol; Pridazole; Priscol; Priscoline )
Catalog No. M27407 CAS No. 59-98-3
Tolazoline, a non-selective competitive α-adrenergic receptor antagonist, is used as a vasodilator to treat spasms of peripheral blood vessels.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
500MG | 45 | Get Quote |
|
1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameTolazoline
-
NoteResearch use only, not for human use.
-
Brief DescriptionTolazoline, a non-selective competitive α-adrenergic receptor antagonist, is used as a vasodilator to treat spasms of peripheral blood vessels.
-
DescriptionTolazoline, a non-selective competitive α-adrenergic receptor antagonist, is used as a vasodilator to treat spasms of peripheral blood vessels. It has also been used successfully as an antidote to reverse the severe peripheral vasoconstriction as a result of overdose with certain 5-HT2A agonist drugs.
-
SynonymsVasimid; Benzalolin; Divascol; Pridazole; Priscol; Priscoline
-
PathwayAngiogenesis
-
TargetAdrenergic Receptor
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number59-98-3
-
Formula Weight160.2
-
Molecular FormulaC10H12N2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESC(C1=NCCN1)c1ccccc1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Shotton DM, et, al. Amino-acid sequence of porcine pancreatic elastase and its homologies with other serine proteinases. Nature. 1970 Feb 28;225(5235):802-6.
molnova catalog
related products
-
Diosgenin glucoside
Diosgenin glucoside and other synthetic glycosides with similar activities may be of use in the management of hypercholesterolemia and atherosclerosis.
-
Dabuzalgron
Dabuzalgron is an orally active selective alpha-1A adrenergic receptor agonist used to treat urinary incontinence. Dabuzaron prevents cardiotoxicity caused by doxorubicin by maintaining mitochondrial function.Dabuzaron treatment increased ERK phosphorylation in a dose-dependent manner with an EC50 of 4.8 μM.
-
Metoprolol
A selective β1 receptor blocker used in treatment of several diseases of the cardiovascular system, especially hypertension.